Frontiers Lu-177-PSMA dosimetry for kidneys and tumors based on
4.9 (354) · $ 6.99 · In stock
Fitting models of the reference 4TP for (A) kidneys and (B) tumors
Practical Guidance on [177Lu]Lu-PSMA-617 Treatment, Including
Tumor and organ dosimetry from sequential quantitative SPECT/CT
A review of advances in the last decade on targeted cancer therapy
Lutetium-177 prostate-specific membrane antigen (PSMA
Frontiers Precision strikes: PSMA-targeted radionuclide therapy
Theranostics and artificial intelligence: new frontiers in
Pre-therapeutic dosimetry of normal organs and tissues of 177Lu
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T
Determination of pharmacokinetics and tissue distribution of a
3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with
Application of machine learning to pretherapeutically estimate
